BioSig Technologies, Inc. STEX Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $5M+41.6% | $3.53M+68.8% | $2.09M+229% | $636K+385% | $131K-30.3% | ||
| -$2.91M-1,585% | $196K-74.7% | $774.75K-42.8% | $1.35M-30.0% | $1.93M-23.0% | ||
| —— | —— | —— | —— | —— | ||
| -$506.66M-9.5% | -$462.78M-1,061% | -$39.87M-52.2% | -$26.2M-169% | -$9.74M+5.7% | ||
| -$9.71-1.4% | -$9.58-594% | -$1.38-34.0% | -$1.03-74.6% | -$0.59+27.2% | ||
| 283.6M+118% | 129.8M+35.4% | 95.9M+21.8% | 78.7M+23.1% | 63.9M+20.6% | ||
| 283.6M+118% | 129.8M+35.4% | 95.9M+21.8% | 78.7M+23.1% | 63.9M+20.6% | ||
| -$5.76M+17.9% | -$7.02M— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | $8.05M— | —— | —— | —— | ||
| $80.4M+40.8% | $57.1M+589% | $8.29M-7.5% | $8.96M+11.7% | $8.02M+14.5% | ||
| -$507.76M-9.9% | -$461.96M-1,036% | -$40.65M-64.9% | -$24.66M-153% | -$9.74M+5.7% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | -$102K+29.7% | -$145K+45.7% | -$267K+13.3% | -$308K+12.0% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $48.54M-11.5% | $54.88M+203% | $18.1M+285% | $4.7M-40.3% | $7.87M+67.1% | ||
| —— | —— | —— | —— | —— | ||
| -$19.5M-86.8% | -$10.44M-32.3% | -$7.89M-81.1% | -$4.36M+4.5% | -$4.56M+4.2% | ||
| —— | $96K-29.9% | $137K-43.6% | $243K-13.2% | $280K-11.4% | ||
| —— | —— | —— | —— | $3.99M-5.3% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| -$98.85M-46.3% | -$67.56M-137% | -$28.55M-6.4% | -$26.85M-119% | -$12.28M+3.1% | ||
| -$103.86M-46.1% | -$71.1M-132% | -$30.65M-11.5% | -$27.48M-121% | -$12.41M+3.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is BioSig Technologies, Inc.'s revenue?
- BioSig Technologies, Inc. (STEX) generated $40.0K in revenue over the trailing twelve months, up 122.2% year over year.
- Is BioSig Technologies, Inc. profitable?
- BioSig Technologies, Inc. is not currently profitable: it reported a net loss of $506.7M over the trailing twelve months, a -25825.0% net margin.
- What are BioSig Technologies, Inc.'s profit margins?
- Gross margin is 80.1% and operating margin is -32155.0%, with a -25825.0% net margin.
- What is BioSig Technologies, Inc.'s earnings per share?
- BioSig Technologies, Inc.'s diluted EPS over the trailing twelve months is $-9.71.
- Where does BioSig Technologies, Inc.'s income statement data come from?
- Every line is extracted from BioSig Technologies, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
